Lightlake Therapeutics Clinical Trial Supports Nasal Spray Version of Naloxone

Lightlake Therapeutics Clinical Trial Supports Nasal Spray Version of Naloxone
Filed under: cocaine treatment agonist
London-based Lightlake is working on treatments for a variety of addictions and disorders, such as Binge Eating Disorder, or "BED," and addictions to drugs including, cocaine, amphetamines and MDMA (the chemical used in ecstasy, but also abused in … Read more on Baystreet.ca

 

What you should know about medical marijuana
Filed under: cocaine treatment agonist
… altered sense of time, analgesia, increased appetite, and impaired memory. CBD is a nonpsychoactive compound that is a serotonin receptor agonist with anti-inflammatory and neuroprotective effects.4 … syndrome when chronic marijuana use is … Read more on Clinical Advisor